Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Vestas wins 256 MW order of V120-2.2 MW turbines in US with 10-year service agreement

News release from Vestas-American Wind TechnologyPortland, 30 September 2019 Vestas has received an order for 256 MW of V120-2.2 MW turbines for a wind project in the U.S. The order includes supply and commissioning of the turbines as well as a 10-year service agreement, designed to ensure optimised performance for the lifetime of the project. Turbine delivery will begin in the second quarter of 2020 with commissioning scheduled for the fourth quarter of 2020. The project and customer are undisclosed. For more information, please contact:Chante Condit-PottolCommunications

Vestas wins 134 MW order of V110-2.0 MW turbines in US

News release from Vestas-American Wind TechnologyPortland, 30 September 2019 Vestas has secured an order for 134 MW of V110-2.0 turbines for a wind project in the U.S. Including previously purchased 2 MW components, the project has a total nameplate capacity of 150 MW. The order includes supply and commissioning of the turbines as well as a multi-year service agreement, designed to ensure optimised performance for the lifetime of the project. Turbine delivery will begin in the second quarter of 2020 with commissioning scheduled for the fourth quarter of 2020. The project and

Diaverum continues international expansion with entry into Albania

Malmö, September 30th2019 - Diaverum, the global renal care provider, expands into Albania through the acquisition of DiaVita Shpk. DiaVita Shpk operates five dialysis clinics across Albania and provides renal care services to over 370 patients.Diaverum is pleased to announce its expansion into Albania, through the acquisition of DiaVita Shpk, a company operating five dialysis clinics located in cities across Albania. The acquisition is in line with Diaverum's strategy to continue to grow through M&A into new markets where Diaverum sees significant growth opportunities. Diaverum has

Sollentuna Stinsen JB AB updates regarding the redemption of its outstanding SEK 300,000,000 bond loan with ISIN: SE0010100966

We refer to the outstanding SEK 300,000,000 senior secured floating rate bonds 2017/2020 with ISIN SE0010100966 (the "Bonds") issued by Sollentuna Stinsen JV AB (”Sollentuna Stinsen") and to the terms and conditions of the Bonds (the "Terms and Conditions"). Reference is further made to a call notice dated 11  September 2019, in which Sollentuna Stinsen informed the holder of the Bonds that it exercises its option to redeem all outstanding Bonds in full pursuant to Clause 9.3 (Voluntary Total Redemption) of the Terms and Conditions (the "Call Notice"), on 8 October 2019 (the "Redemption

Vestas wins largest EnVentus order to date with project in Finland

News release from Vestas Northern and Central EuropeHamburg, 30 September 2019 Glennmont Partners has together with the Finnish developer Ilmatar Energy placed an order with Vestas for the 211 MW Piiparinmäki wind project in the municipalities of Pyhäntä and Kajaani in Finland. Once constructed, the Piiparinmäki project will be the largest wind park in the country and it is the first Anti-Icing order for the EnVentus platform. Furthermore, a majority of the offtake from the project is backed by a corporate power purchase agreement (PPA) with Google, enabling the project to be built on

Bulten earnings for the third quarter were negatively affected by restructuring in Germany and lower production rate

Bulten AB (publ) releases its full report for the third quarter on October 24, 2019. As previously announced, restructuring is underway in the company's unit in Bergkamen, Germany. The restructuring is expected to generate an annual saving of approximately SEK 25 million from the calendar year 2020. Costs for the restructuring are expected to amount to approximately SEK 20 million, which will be charged to the third quarter 2019. Continued decline in the automotive markets and the adaptation of production to demand impacted the company's earnings during the third quarter by approximately SEK

Change in the number of shares and votes in Starbreeze

STOCKHOLM, SWEDEN (30 September 2019) – Starbreeze AB today announces that the number of Class B shares increased by 55,600 and the number of Class A shares decreased by the same number during September due to the company’s ongoing conversion program. The number of votes decreased by 500,400. In accordance with the articles of association Class A shares shall, upon request of the holder of such shares, be converted into Class B shares. In September 55,600 Class A shares were converted into Class B shares, which did not change the total number of shares but reduced the number of votes.

Resolutions at the extraordinary general meeting in Volati AB (publ)

At the extraordinary general meeting in Volati AB (publ) today on 30 September 2019, it was resolved on approval of the so-called Leo-transactions, whereupon key employees of subsidiaries of Volati are given an opportunity to invest in shares in the subsidiaries. The transactions are part of Volati’s business model, which is to create a mutual interest with key employees within its business units by way of co-investments. In addition, the general meeting also resolved on redemption of 1,000,000 own ordinary shares held by the company. Transfer of shares in subsidiaries to Volati AB to

Vestas secures order for two merchant repowering projects in Italy

News release from Vestas MediterraneanMadrid, 30 September 2019 E2i Energie Speciali has placed a 43 MW order for two merchant repowering projects in the province of Chieti, Italy. By applying market experience and operational data from two existing wind farms, Vestas and E2i have been able to create a custom repowering solution that doubles the wind farms’  combined energy production, reduces the number of turbines by 70 per cent, and – most notably – allows the operation of the two wind farms on a purely merchant basis and without any direct financial support. For the

Bonava acquires Urbanium AS – a leading residential developer in the Oslo region

Bonava acquires the residential developer Urbanium AS for MNOK 608 on a cash and debt free basis. Urbanium’s business mainly consists of a land portfolio in the Oslo region. With this transaction, Bonava strengthens its position on the Norwegian market.Bonava Norge AS, a wholly owned subsidiary of Bonava AB (publ), has today entered an agreement to acquire all shares in Urbanium AS. Urbanium has since 2003 developed and sold residential units in Oslo as well as in central suburban regions around Oslo. The company has over the last years, bought and developed an attractive land portfolio

Vestas secures order from Iberdrola for the first V150-4.2 MW turbines in Greece

News release from Vestas MediterraneanMadrid, 30 September 2019   Vestas has won a 16 MW auction-derived order from Iberdrola for the Pyrgari wind park located in Viotía, Greece. The contract includes the supply and installation of four V150-4.2 MW wind turbines delivered in 4.0 MW operating mode, as well as a 10-year Active Output Management 5000 (AOM 5000) service agreement. The Pyrgari wind park, which was awarded in the renewable energy auction held in Greece in July 2018, reinforces Vestas’ leadership in the Greek auctions where it has won more of the auctioned capacity than

Moberg Pharma and Taisho sign exclusive license agreement for MOB-015 in Japan

STOCKHOLM, September 30th, 2019, Moberg Pharma AB (OMX: MOB) has signed an exclusive license agreement with Taisho Pharmaceutical Co., Ltd for development, registration and commercialization of MOB-015 in Japan. Under the agreement, Moberg Pharma is eligible to receive milestones of up to USD 50 million contingent on development and commercial success, as well as supply fees including royalties.Moberg Pharma has entered into a license agreement granting Taisho Pharmaceutical Co., Ltd exclusive Japanese rights to MOB-015, a new topical treatment of onychomycosis based on Moberg’s patented

Notice of Annual General Meeting in Moberg Pharma AB (publ)

Shareholders in Moberg Pharma AB (publ) (reg. no. 556697-7426) (the “Company”) are hereby convened to the Annual General Meeting on Wednesday, 30 October 2019, at 4:00 p.m. (CET) in the Company’s premises in Bromma, address Gustavslundsvägen 42, 5 tr, 167 51 Bromma (Alviks torg), Sweden.Attendance at the Annual General MeetingShareholders who wish to participate in the Annual General Meeting must: -        be recorded in the share register maintained by Euroclear Sweden AB (“Euroclear”) on Thursday, 24 October 2019, and -        give notice of attendance to the Company under address:

Changes in the Management Board of Swedbank Estonia

The Council of Swedbank Estonia has decided to appoint Olavi Lepp as permanent CEO, and Anna Kõuts as permanent CFO of Swedbank Estonia. Following a Council decision, three members of the Management Board will leave their positions and the bank.“The change in leadership will take Swedbank Estonia forward. Olavi Lepp and Anna Kõuts are both experienced banking leaders and have contributed strongly to the development of Swedbank”, says Björn Elfstrand, Council Chair of Swedbank Estonia. “Our commitment to develop Swedbank in Estonia with our customers and society in focus is strong and

Össur hf: Transactions in relation to share buyback program

Announcement no. 57/2019 30 September 2019On 10 September 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 53/2019. The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 31 December 2019. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.2% of the current share capital. The total consideration for shares purchased under

Moberg Pharma proposes to pay the shareholders SEK 46.50 per ordinary share and repays the MOB-015 loan

STOCKHOLM, September 30th, 2019. As previously communicated, Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company"), intends to propose the Annual General Meeting for the abbreviated financial year 2019 to resolve on a payment to the shareholders through redemption of shares. The Board of Directors has now set the proposed redemption amount to SEK 46.50 per share. Moberg Pharma also announces that the Company intends to repay the loan of USD 2.5 million that the Company incurred from the purchaser in connection with the divestment of the Company's OTC-business last spring.Moberg Pharma

Kai Wärn to become Chairman of the Board of Electrolux Professional AB

The Board of Directors of AB Electrolux (“Electrolux”) today announced the appointment of Kai Wärn as Chairman of the Board of Directors of Electrolux Professional AB (“Electrolux Professional”), the company intended to be distributed to AB Electrolux shareholders in 2020.As previously announced, Electrolux Professional is intended to be distributed to the shareholders of Electrolux and listed during the first half of 2020, subject to shareholder approval. As a step in the preparations for the distribution and intended listing, Electrolux has appointed Kai Wärn as Chairman of the Board of

SRV Group Plc - Managers' transactions

SRV GROUP PLC    MANAGERS' TRANSACTIONS    30 SEPTEMBER 2019    19.00 EET SRV Group Plc - Managers' transactions Notification under the EU Market Abuse Regulation, article 19 Person subject to the notification requirementName: Havu Capital Oy Legal PersonPosition: Closely associated person Person discharging managerial responsibilities in issuerName: Kokkila TimoPosition: Member of the Board/Deputy member      Initial

SRV Group Plc: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

SRV GROUP PLC                      STOCK EXCHANGE RELEASE             30 SEPTEMBER 2019    18.50 EET SRV Group Plc: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 SRV Group Plc has received an announcement from Timo Tapani Kokkila on 30 September 2019, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcementTimo Tapani Kokkila’s direct holding in SRV Group Plc ‘s shares decreased below 5 per cent and his indirect holding through Havu Capital Oy, a company controlled by him, exceeded over 10 per cent of the

OrganoClick explores the conditions for carrying out a directed share issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, SOUTH KOREA OR THE UNITED STATES OF AMERICA, OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR SUBJECT TO LEGAL RESTRICTIONS. PLEASE SEE IMPORTANT INFORMATION BELOW. OrganoClick AB (publ) (”OrganoClick” or ”the Company”) has engaged ABG Sundal Collier to explore the conditions for carrying out a directed share issue corresponding to a value of circa SEK 65 million through an

Change in number of shares and votes in Hembla

The number of shares of series B and votes in Hembla AB (publ) has changed during the month of September as a result of the exercise of 97,000 warrants, in exchange for 100,589 shares of series B, within the framework of the company’s incentive program which was adopted at the annual general meeting 2016. As of the last trading day of the month there were in total 92,924,306 shares in the company, whereof 6,136,989 shares of series A and 86,787,317 shares of series B, and 117,472,262 votes in the company. For more information, please contactSvein Erik Lilleland, CEO, Phone: +46 (0) 8

Number of shares and votes in Samhällsbyggnadsbolaget i Norden AB (publ)

Pursuant to the Swedish Financial Instruments Trading Act, Swedish companies whose shares are listed on a regulated market and that increase or reduce the total number of shares or votes in the company must disclose such changes on the last trading day the same month. As of 30 September 2019, there are 832,577,974 shares and 272,237,539 votes in Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) distributed as follows: Common shares class A: 209,977,491 shares and 209,977,491 votes Common shares class B: 546,071,540 shares and 54,607,154 votes Common shares class D: 76,498,230

EAB GROUP PLC: ACQUISITION OF OWN SHARES 30.09.2019

EAB GROUP PLC  NOTIFICATION 30.09.2019 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 30.09.2019 Date 30.09.2019Exchange transaction BuyShare class EABAmount 190 Average price/share 2.8400 EUR  Highest price/share 2.8400 EUR Lowest price/share 2.8400 EUR Total price  539.60 EUR  The shares held by EAB Group Plc on 30.09.2019: EAB 1,865 On behalf of EAB Group Plc Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Mikko Virtanen For more information, please

There are no items matching the current filter
There are no more items matching the current filter
Back to top